FDA Inspection 1323146 — Brigham And Women's Hospital, Inc., The

Brigham And Women's Hospital, Inc., The — FEI 3012030543

The FDA completed an inspection of Brigham And Women's Hospital, Inc., The on Jun 22, 2026 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 22, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
2137621 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.